Farmeconomia-Health Economics and Therapeutic Pathways
Scope & Guideline
Driving the future of health economics with open access knowledge.
Introduction
Aims and Scopes
- Health Economics and Pharmacoeconomics:
The journal emphasizes the economic evaluation of healthcare interventions, including cost-effectiveness analyses and pharmacoeconomic assessments to inform drug pricing and reimbursement decisions. - Health Technology Assessment (HTA):
It covers comprehensive evaluations of health technologies, assessing their clinical effectiveness, safety, and economic impact, which is essential for informed policy-making. - Real-World Evidence (RWE):
The journal highlights the importance of real-world evidence in understanding treatment effectiveness and patient outcomes outside controlled clinical trials. - Patient-Centered Outcomes:
Research often focuses on the impact of treatments on patient quality of life and healthcare resource utilization, ensuring that patient perspectives are central to economic evaluations. - Cost Analysis in Specific Disease Areas:
The scope includes detailed economic analyses for various diseases, such as diabetes, cancer, and mental health disorders, providing insights into the financial implications of different treatment strategies.
Trending and Emerging
- Long-Acting Injectable Therapies:
There is a growing focus on the clinical and economic potential of long-acting injectable therapies, particularly in mental health and chronic conditions, reflecting a shift towards treatments that improve adherence and outcomes. - Biosimilars and Their Economic Implications:
Research on biosimilars, including their procurement and budget impact, is trending upward as healthcare systems look for cost-effective alternatives to expensive biologics. - Budget Impact Analyses in Vaccination Programs:
The importance of budget impact analyses in vaccination strategies, particularly for influenza and other vaccines, is gaining traction as public health priorities shift towards preventative healthcare. - Integrated Care Models and Multi-Disease Approaches:
Emerging studies are increasingly examining integrated care models that address multiple chronic conditions simultaneously, reflecting a holistic approach to patient management and economic evaluation. - Use of Wearable Health Technologies:
The assessment of wearable health technologies and their impact on patient management and health outcomes is becoming a prominent theme, driven by advancements in technology and patient engagement.
Declining or Waning
- Traditional Cost-Benefit Analyses:
There has been a noticeable decline in traditional cost-benefit analyses that do not incorporate broader patient-centered outcomes or real-world evidence, suggesting a shift towards more comprehensive evaluation frameworks. - Generic Drug Assessments:
Research specifically focused on the economic evaluation of generic drugs seems to be waning, potentially due to a saturation of studies in this area and a preference for innovative therapies. - Single-Disease Focus Studies:
There appears to be a reduction in studies concentrating solely on single-disease economic evaluations, with an increasing trend toward integrated care models that consider multiple conditions and their interactions. - Basic Economic Modelling Techniques:
The journal has seen fewer publications relying on basic economic modelling techniques, with a growing preference for sophisticated models that incorporate real-world complexities and uncertainties.
Similar Journals
Pharmacoeconomics-Open
Advancing Access to Critical Health Policy ResearchPharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.
HEALTH TECHNOLOGY ASSESSMENT
Advancing the future of healthcare through rigorous technology assessment.HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.
Health Economics Review
Transforming health policy through innovative research.Health Economics Review is a premier, peer-reviewed journal dedicated to advancing knowledge and research in the dynamic field of health economics and policy. Published by BMC, this Open Access journal has been a vital resource since 2011, providing a platform for scholars and practitioners to share their findings and insights on pressing health policy issues. With an impressive Q2 ranking in the Health Policy category and a Scopus rank of 113 out of 310, it reflects a solid standing within the academic community, capturing a 63rd percentile ranking that underscores its contribution to the field. The journal covers an extensive range of topics including health systems, economic evaluations, and policy analysis, making it essential reading for researchers, health professionals, and policymakers. Located in Germany, with an operational address at CAMPUS, 4 Crinan St, London, the journal is committed to fostering innovation and collaboration in health economics, thereby shaping a healthier future for all.
Applied Health Economics and Health Policy
Unlocking the potential of health economics for global well-being.Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.
European Journal of Health Economics
Transforming Health Policy Through Economic InsightThe European Journal of Health Economics, published by SPRINGER, is a premier interdisciplinary journal dedicated to advancing research in the intersection of health policy and economic theory. With an impressive impact factor and consistently ranked in the Q1 category in both Economics and Health Policy (2023), this journal serves as a vital platform for disseminating innovative research findings and practical insights relevant to today's healthcare challenges. Covering a broad spectrum of topics, from health care financing and economic evaluation to policy analysis, the journal aims to foster dialogue among academics, policymakers, and practitioners alike. Published continuously from 2002 to 2024, the European Journal of Health Economics holds its rank within the top 12% of Economics and Finance journals and the top 16% in Medicine. Researchers and students looking to stay abreast of the latest trends and methodologies in health economics will find this journal an invaluable resource.
AMERICAN JOURNAL OF MANAGED CARE
Connecting evidence-based practices to real-world solutions.AMERICAN JOURNAL OF MANAGED CARE is a premier peer-reviewed journal dedicated to the dissemination of research and insights in the fields of health policy and managed care. Published by Managed Care & Healthcare Communications LLC, this esteemed journal has been instrumental in shaping discussions on healthcare management and policy since its inception in 1996. With a 2023 classification in the first quartile (Q1) for both Health Policy and Medicine (miscellaneous), it stands as a significant resource for researchers, professionals, and students seeking to stay at the forefront of healthcare advancements. While this journal does not offer open access, it provides essential content that influences policy formulation and clinical practices across the United States and beyond. With a robust impact factor and a strategic focus on evidence-based methodologies, the AMERICAN JOURNAL OF MANAGED CARE remains committed to fostering a deeper understanding of managed care systems and improving healthcare delivery.
ClinicoEconomics and Outcomes Research
Advancing Health Economics for Better OutcomesClinicoEconomics and Outcomes Research is a prestigious open-access journal published by DOVE MEDICAL PRESS LTD, located in New Zealand. Since its inception in 2009, it has established itself as a vital resource for researchers and practitioners in the fields of economics, health policy, and outcomes research. With a commendable impact reflected in its rankings—Q1 in Economics, Econometrics and Finance and Q2 in Health Policy—the journal effectively bridges the gap between economic evaluation and healthcare delivery. This publication is particularly significant for those focused on the economic implications of health interventions, policy analysis, and decision-making processes in healthcare systems. As an open-access journal, ClinicoEconomics and Outcomes Research ensures that its valuable content is widely accessible, enhancing knowledge dissemination and fostering collaboration among academia, industry, and policymakers. With an ambition to contribute to the improvement of health outcomes through rigorous research, it invites submissions that address the multifaceted challenges facing the economics of healthcare today. Join the scholarly dialogue where innovative ideas in health economics thrive!
MDM Policy & Practice
Driving Progress in Health Policy and PracticeMDM Policy & Practice is a premier open-access journal published by SAGE Publications Inc, focusing on the critical fields of Health Policy and Public Health, Environmental and Occupational Health. Since its inception in 2016, this journal has aimed to provide an authoritative platform for disseminating research findings, policy discussions, and innovative practices that drive improvements in health systems globally. With an impact factor that reflects its growing influence in the academic landscape, it holds a Q2 ranking in both Health Policy and Public Health categories as of 2023. This journal leverages its accessibility to foster a collaborative environment for researchers, policymakers, and practitioners alike, encouraging the exchange of ideas and knowledge to address pressing health challenges. Operating under a commitment to open access, MDM Policy & Practice ensures that vital research is available to a wider audience, fostering informed decision-making and progressive advancements in the health policy sphere.
JOURNAL OF HEALTH ECONOMICS
Empowering Decisions with Evidence-Based Health EconomicsJOURNAL OF HEALTH ECONOMICS, published by Elsevier, is a leading peer-reviewed journal in the fields of health policy and public health, with an impressive impact factor indicative of its significance in academic research. Since its inception in 1982, the journal has been a pivotal platform for disseminating impactful research that influences health care policies and economic evaluations, addressing critical topics that drive effective health care delivery and resource allocation. With its current ranking of Q1 in both Health Policy and Public Health, Environmental and Occupational Health, it is recognized among the top journals in these areas, boasting a Scopus rank that places it in the top percentiles of health-related publications. Although it operates under a subscription model, researchers and practitioners benefit from its rich repository of studies and analysis that advance knowledge and practice in health economics. The journal remains committed to fostering interdisciplinary dialogue, making it an invaluable resource for researchers, professionals, and students committed to improving health systems and outcomes.
CURRENT MEDICAL RESEARCH AND OPINION
Empowering Medical Minds Through Rigorous Research.CURRENT MEDICAL RESEARCH AND OPINION, published by Taylor & Francis Ltd, is a distinguished journal that has been at the forefront of medical research since its inception in 1972. With a vested interest in advancing healthcare knowledge, this journal encompasses a wide array of disciplines within the medical field, categorizing itself in Q2 of the Medicine (Miscellaneous) category according to the 2023 rankings. Notably, it holds a commendable rank of #119 out of 636 in the General Medicine category on Scopus, indicating its relevance and influence within the medical community, supported by an 81st percentile ranking. Although it does not present Open Access options, the comprehensive research articles, systematic reviews, and expert opinions it publishes are crucial for researchers, clinicians, and students who seek to deepen their understanding and drive innovations in medical practice. With its commitment to high-quality and impactful scientific communication, CURRENT MEDICAL RESEARCH AND OPINION remains an essential resource for those dedicated to advancing healthcare and improving patient outcomes.